SHR2554 plus hormone therapy for advanced breast cancer
Part of Cancer, Hormones & metabolism clinical trials.
This trial tests a new drug, SHR2554, combined with hormone therapy for people with advanced or metastatic breast cancer. It aims to see if the combination can help control the cancer when standard treatments are no longer working.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- Your breast cancer has spread to other parts of the body (advanced or metastatic).
- You are able to take care of yourself and are up and about (ECOG score 0 or 1).
- You have at least one tumor that can be measured on scans.
- Your organs (like liver, kidneys, blood) are working well enough.
- If you could become pregnant, you agree to use effective birth control during the study and for 7 months after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug SHR-A2102 combined with other treatments for advanced or metastatic breast cancer. It aims to see if the combination is safe and effective.
This trial tests a combination of two drugs—SHR-A1921 (a targeted therapy) and Adebrelimab (an immunotherapy)—for people with a specific type of advanced breast cancer (HR-positive, HER2-negative, PD-L1 positive). It aims to see if this combo can help when hormone therapy and chemotherapy haven't worked well enough.
This trial tests a combination of an antibody-drug conjugate (ADC) and an immunotherapy drug (adebrelimab) for people with advanced HER2-negative breast cancer that has stopped responding to prior treatments. The goal is to see if this combination can help shrink or slow the cancer.
This trial tests two drugs, HRS-4642 and SHR-A2102, for people with advanced solid tumors that cannot be removed by surgery or have spread. The goal is to see if this combination can help shrink or slow tumor growth.
This trial tests a combination of new drugs (HRS-8080, SHR-A2009, or others) for people with advanced breast cancer that has stopped responding to previous treatments. The goal is to see if these combinations can shrink tumors or slow the cancer's growth.
This trial tests a new drug called SHR-4602, alone or with other cancer treatments, for people with advanced solid tumors that have HER2 protein. It may be an option if you have already tried standard therapies and your cancer is still growing.
Hear when a new Advanced Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.